Petros Karakousis is an Infectious Disease physician affiliated with Johns Hopkins University. OpenAlex indexes 263 publications with 7,215 citations (h-index 46); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
600 N Wolfe St
Baltimore, MD 212870005
Telephone
410-955-1725Registry record last updated 8 Jul 2007.
Clinical trials
- StAT-TB (Statin Adjunctive Therapy for TB): A Phase 2b Dose-finding Study of Pravastatin in Adults With Tuberculosis
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
40.3%Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor19.4%Triumeq53%Descovy47%Part D<11 patientsHuman Immunodeficiency Virus Integrase Strand Transfer Inhibitor14.3%Tivicay100%Part D≥12 patients+ 1 more class in this area
Cardiovascular
38.6%Statin18.6%Atorvastatin Calcium100%Part D≥13 patientsCalcium channel blocker6.9%Amlodipine Besylate54%Nifedipine Er46%Part D<11 patients+ 3 more classes in this area
Metabolism & gastrointestinal
9.4%DPP-4 inhibitor6.3%Januvia100%Part D<11 patientsGLP-1 receptor agonist3.1%Rybelsus100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
14 NIH research awards on record, funded 2005–2026 per NIH RePORTER. The latest:
- JHU TRAC: Training and Supporting the Next Generation of TB Researchers
Johns Hopkins University
FY2026$980,676P30AI168436 - Advancing Apoptosis-Inducing Agents as Host-Directed Therapy for TB
Johns Hopkins University
FY2025$2,922,220R01AI186308
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Association of Lipid Levels With COVID-19 Infection, Disease Severity and Mortality: A Systematic Review and Meta-Analysis
Frontiers in Cardiovascular Medicine
2022 - Modes of transmission of SARS-CoV-2 and evidence for preventive behavioral interventions
BMC Infectious Diseases
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Roger Blumenthal, MD
Johns Hopkins University
Erin Michos, MD
Johns Hopkins University
Morgan Grams, MD
Johns Hopkins University
Mario Eisenberger, MD
Johns Hopkins University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”